Retatrutide - (“Reta/GLP3/Pep3")

(“Reta/GLP3/Pep3")has been the subject of ongoing clinical investigation for obesity and metabolic research applications.

Published studies and research observations have described:

• Significant reductions in body weight
• Reduced appetite and caloric intake
• Improvements in glycemic markers and HbA1c
• Positive changes in liver fat and metabolic health markers

In Phase 2 clinical research involving obesity and type 2 diabetes, investigators observed clinically meaningful reductions in HbA1c and body weight across multiple dosing groups.

Additional liver-focused research demonstrated substantial reductions in liver fat content in participants with fatty liver disease (NAFLD/MASLD). In one substudy, many participants receiving higher-dose retatrutide no longer met criteria associated with fatty liver disease following the research period.

Researchers have also observed improvements in:

• Insulin sensitivity
• Lipid profiles
• Metabolic biomarkers
• Body composition and fat mass distribution

Community research discussions commonly describe:

• Appetite suppression
• Increased satiety
• Progressive body composition changes
• Improved adherence to calorie-controlled protocols

Research observations are anecdotal and are not clinical claims. Results may vary. Products are intended strictly for laboratory research use only.

Published Research Sources

• PubMed
• NIH / NCBI
• New England Journal of Medicine
• The Lancet
  

   

Ipamorelin 

Ipamorelin (“Ipa”) has been investigated in growth hormone and metabolic research for its selective stimulation of endogenous GH release.

Published studies and research observations have reported:

• Increased growth hormone (GH) secretion
• Elevated IGF-1 levels in research settings
• Potential support for lean body mass preservation
• Reduced body fat and improved body composition markers
• Recovery and tissue-repair related observations
• Sleep and recovery support in some research models
• Minimal impact on cortisol and prolactin compared with earlier GHRP compounds
• Selective ghrelin receptor activity under laboratory conditions

In clinical and preclinical research, investigators observed that Ipamorelin stimulated growth hormone release while maintaining a comparatively favorable selectivity profile versus older GH secretagogues.

Additional experimental research has explored potential applications involving:

• Muscle preservation research
• Recovery pathway studies
• Healthy aging investigations
• Metabolic and wellness-related research models
• Exercise and performance recovery research

Researchers continue evaluating Ipamorelin for its role in GH/IGF-1 signaling and its broader implications in metabolic and regenerative research.

 

BPC-157 

BPC-157 (“Body Protection Compound-157”) has been the subject of ongoing experimental and preclinical research involving tissue-repair and recovery pathways.

Published studies and research observations have reported:

• Tendon and ligament healing support in animal research models
• Gastrointestinal protective effects under laboratory conditions
• Angiogenesis and blood vessel formation activity in experimental studies
• Muscle and soft tissue recovery observations
• Investigational effects involving inflammatory-response pathways
• Support for wound-healing processes in preclinical research
• Neuroprotective and regenerative signaling observations in experimental models
• Potential interactions with nitric oxide and growth-factor pathways

Researchers have investigated BPC-157 across multiple laboratory models involving musculoskeletal, gastrointestinal, and recovery-related applications.

Additional experimental research has explored potential applications involving:

• Tendon-to-bone healing research
• Joint and connective tissue investigations
• Recovery pathway studies
• Gastrointestinal integrity research
• Exercise and performance recovery models

Researchers continue evaluating BPC-157 for its role in regenerative and recovery-related signaling pathways.

 

TB-500

TB-500 (Thymosin Beta-4 Fragment) has been investigated in regenerative and recovery-focused research involving tissue repair, cellular migration, and recovery signaling pathways.

Published studies and research observations have reported:

• Support for wound-healing processes in experimental models
• Tendon and ligament recovery observations
• Muscle recovery and tissue-repair related findings
• Cell migration and angiogenesis activity in laboratory research
• Reduced inflammation markers in preclinical studies
• Flexibility and mobility-related observations in animal research
• Investigational effects on actin regulation and cellular repair mechanisms
• Recovery-support signaling in musculoskeletal research models

Researchers have explored TB-500 in multiple experimental settings involving connective tissue, injury recovery, and regenerative biology.

Additional experimental research has explored potential applications involving:

• Tendon and ligament recovery research
• Muscle repair investigations
• Joint and connective tissue studies
• Exercise and performance recovery models
• Cellular regeneration and healing pathway research

Researchers continue evaluating TB-500 for its broader role in tissue-repair and regenerative signaling pathways.

 

SS-31

SS-31 (Elamipretide) has been investigated in mitochondrial and cellular-energy research for its potential role in supporting mitochondrial function and reducing oxidative stress.

Published studies and research observations have reported:

• Improved mitochondrial bioenergetics in experimental models
• Reduced oxidative stress markers under laboratory conditions
• Enhanced cellular energy production research findings
• Muscle endurance and fatigue-related observations
• Cardiovascular and skeletal muscle research applications
• Neuroprotective and cellular-protection signaling in preclinical studies
• Investigational effects on mitochondrial membrane stabilization
• Recovery and healthy-aging related research observations

Researchers have explored SS-31 across multiple experimental settings involving mitochondrial dysfunction, metabolic health, and cellular recovery pathways.

Additional experimental research has explored potential applications involving:

• Exercise and endurance research
• Healthy aging investigations
• Cardiovascular research models
• Neurological and cognitive pathway studies
• Muscle recovery and metabolic signaling research

Researchers continue evaluating SS-31 for its broader role in mitochondrial support and cellular-energy regulation.

 

MOTS-C

MOTS-c is a mitochondrial-derived peptide that has been investigated in metabolic and cellular-energy research involving mitochondrial function, exercise physiology, and metabolic regulation pathways.

Published studies and research observations have reported:

• Improved metabolic function in experimental models
• Enhanced glucose utilization and insulin-sensitivity related findings
• Increased exercise endurance and performance observations
• Mitochondrial energy-production support under laboratory conditions
• Fat metabolism and weight-management related research findings
• Cellular stress-response and adaptive signaling activity
• Healthy-aging and longevity-related investigative research
• Exercise-mimetic effects in preclinical studies

Researchers have explored MOTS-c across multiple experimental settings involving metabolism, mitochondrial biology, and cellular resilience pathways.

Additional experimental research has explored potential applications involving:

• Exercise performance research
• Healthy aging investigations
• Metabolic health and glucose regulation studies
• Weight management and fat metabolism models
• Cellular energy and mitochondrial signaling research

Researchers continue evaluating MOTS-c for its broader role in mitochondrial communication and metabolic regulation pathways.

 

5-Amino-1MQ

5-Amino-1MQ has been investigated in metabolic and body-composition research for its potential role in nicotinamide N-methyltransferase (NNMT) inhibition and cellular energy regulation.

Published studies and research observations have reported:

• Reduced fat accumulation in experimental models
• Increased energy expenditure and metabolic activity findings
• Improved body-composition related observations
• Investigational effects on adipose tissue metabolism
• Support for metabolic efficiency under laboratory conditions
• Cellular energy and NAD+ pathway research activity
• Weight-management related findings in preclinical studies
• Potential influence on glucose and lipid metabolism pathways

Researchers have explored 5-Amino-1MQ across multiple experimental settings involving metabolism, obesity research, and cellular-energy regulation pathways.

Additional experimental research has explored potential applications involving:

• Weight management and fat metabolism research
• Metabolic optimization studies
• Exercise and energy expenditure investigations
• Cellular NAD+ and methylation pathway research
• Healthy aging and metabolic health models

Researchers continue evaluating 5-Amino-1MQ for its broader role in metabolic signaling and body-composition related research.

 

NAD+